Belgian Biotech Raises €30M Series A to Unlock Undruggable Targets
Confo Therapeutics has raised €30M in a Series A round that will take its unique…
07/05/2019 - 3 minutes
Confo Therapeutics
ADVERTISEMENT
Do you want your own advert here? Advertise with us!
Belgian Biotech and Roche Take on Neurological and Developmental Disorders
Confo Therapeutics has joined forces with Roche to develop new small molecule agonists of a…
19/12/2017 - 2 minutes
Belgian Biotech Teams Up With Lundbeck to Collaborate on Drug Discovery
Confo and Lundbeck have joined forces to push through drug discovery against a tough-to-target protein…
26/09/2017 - 2 minutes
A Painful Case: How Biotech is trying to Break Through in Analgesia
Just 2% of experimental pain treatments clear Phase II. Why is this challenge so great,…
06/06/2017 - 7 minutes
Young Belgian Biotech will tackle Fibrosis with a New Grant
Confo Therapeutics has received a €1.6M grant to support the discovery of drugs against fibrosis,…
01/02/2017 - 2 minutes
